Agazi Gebreselassie, MD
Gastroenterology · Glen Burnie, MDNPI 1235572843
Payments from drug & device makers
Across 408 payments — averaging $30.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Olympus Corporation Of The Americas$3K
- Johnson & Johnson$779
- Takeda Pharmaceuticals U.S.A., Inc.$661
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$656
- Bristol Myers Squibb$475
- plus $3K from 28 others
What the payments were for
- Travel & lodging$2,86223%
- Food & beverage$9,36276%
- Education$470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 111 | $3,231 |
| Olympus Corporation Of The Americas | 41 | $3,216 |
| Johnson & Johnson(2 entities) | 29 | $779 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $661 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $656 |
| Bristol Myers Squibb | 30 | $475 |
| Pfizer | 18 | $401 |
| Sanofi | 11 | $294 |
| Lilly USA, LLC | 8 | $211 |
| Intercept Pharmaceuticals, Inc. | 11 | $198 |
| Madrigal Pharmaceuticals | 8 | $190 |
| Conmed Corporation | 2 | $184 |
| Olympus America Inc. | 2 | $182 |
| Ardelyx, Inc. | 8 | $152 |
| Ironwood Pharmaceuticals, Inc | 8 | $146 |
| Amgen(2 entities) | 5 | $129 |
| E.r. Squibb & Sons, L.L.C. | 2 | $115 |
| Mylan Specialty L.p. | 1 | $110 |
| Celltrion USA Inc. | 6 | $108 |
| Gilead | 6 | $101 |
| Regeneron Healthcare Solutions, Inc. | 5 | $93 |
| Redhill Biopharma Inc. | 5 | $89 |
| QOL Medical, LLC | 3 | $79 |
| Fresenius Kabi USA, LLC | 3 | $67 |
| Organon | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| Braintree Laboratories, Inc. | 3 | $55 |
| Boehringer Ingelheim | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 3 | $53 |
| Merck | 2 | $39 |
| Aimmune Therapeutics, Inc. | 1 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Enterra Medical, Inc. | 1 | $17 |
| KARL Storz Endoscopy-america | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavyret$905
- Olympus EMR & ESD Devices$752
- Olympus EUS Devices$752
- Olympus Hemostasis Devices$752
- VISIGLIDE$624
- Single Use Electrosurgical Knife KD-655$461
- Olympus GI Accessories$302
- Single Use Electrosurgical Hemostatic Forceps$286
- SINGLE USE SUCTION VALVE (Sterile)$264
- Single Use Aspiration Needle NA-U200H$250
- XARELTO$217
- DISPOSABLE DISTAL ATTACHMENT$176
- Olympus$176
- CONMED BILIARY$139
- CONMED GENERATORS$139
- CONMED HEMOSTASIS$139
- Yupelri$110
How this compares
$12,271 in reported general payments places this provider in the 75th percentile of 455 gastroenterology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $97,412 |
| XifaxanRifaximin | 13 | $41,242 |
| CreonLipase/Protease/Amylase | 16 | $37,127 |
| VemlidyTenofovir Alafenamide | 11 | $15,540 |
| Pantoprazole Sodium | 156 | $2,719 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 35 | $1,989 |
| Opium Tincture | 11 | $1,974 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 20 | $271 |
| Dicyclomine Hcl | 13 | $269 |
| Spironolactone | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $656 | $41,24213 claims |
| AbbVieCreon | $3,231 | $37,12716 claims |
| GileadVemlidy | $101 | $15,54011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 455 gastroenterology providers in Maryland.
Other gastroenterology in Glen Burnie
- Kenolisa OnwuemeBaltimore$4.5M
- Paul ThuluvathBaltimore$3.6M
- Apurva ModiRockville$3.3M
- Louis KormanChevy Chase$1.9M
- Marcia CantoBaltimore$1.6M
- Michael EpsteinAnnapolis$1.4M
- Rudrajit RaiColumbia$1.4M
- Natarajan RavendhranCatonsville$1.2M
- Raymond CrossBaltimore$1.2M
- Erica CohenChevy Chase$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.